SRZN
SurrozenBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The credible bull case is that Surrozen converts from a preclinical ophthalmology story into a funded clinical-stage story: management reiterated an H2 2026 IND target for SZN-8141, ARVO provides a near-term scientific visibility point, and successful IND clearance could unlock $95.1 million of contingent PIPE proceeds that would extend runway meaningfully [#8-K-2026-03-23] [#10-K-2026-03-23].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +12.1.
What can break
FDA clearance may not arrive by October 31, 2026, preventing the contingent second PIPE closing.
Momentum
38
Value
41
Sentiment
91
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $33.00 · Bull $45.00 · Bear $22.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-22 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $38.50
Why
Momentum38 · Δ7d -26.2
Value41 · Δ7d +0.1
Sentiment91 · Δ7d +12.1
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
38
34% active weight
Current posture
7d trendSoftening
Δ7d
-26.2
Δ21d
-51.4
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
91
33% active weight
Current posture
7d trendImproving
Δ7d
+12.1
Δ21d
+30.0
Why this grade
Composite grade B. Momentum 37.9 / Value 41.1 / Sentiment 90.8
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$286.89M
Beta
0.58
Shares Out
8.57M
P/E (TTM) · Derived
-1.5
P/S (TTM)
45.43
P/FCF (TTM) · Derived
-9.54
Rev YoY
-90.2%
EPS YoY
-1781.6%
Gross Margin
-
Op Margin
-1055.6%
Net Debt
-$34.57M
Current Ratio
13.15
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology